Morcellation of the Uterus: Is There Any Place?
Identifikátory výsledku
Kód výsledku v IS VaVaI
<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F00216208%3A11120%2F20%3A43920211" target="_blank" >RIV/00216208:11120/20:43920211 - isvavai.cz</a>
Výsledek na webu
<a href="https://doi.org/10.1007/s11912-020-00927-6" target="_blank" >https://doi.org/10.1007/s11912-020-00927-6</a>
DOI - Digital Object Identifier
<a href="http://dx.doi.org/10.1007/s11912-020-00927-6" target="_blank" >10.1007/s11912-020-00927-6</a>
Alternativní jazyky
Jazyk výsledku
angličtina
Název v původním jazyce
Morcellation of the Uterus: Is There Any Place?
Popis výsledku v původním jazyce
Purpose of Review: This paper aims to review recent findings related to uterine morcellation. Recent Findings: In 2014, the US Food and Drug Administration (FDA) issued a safety communication warning against the use of laparoscopic power morcellators. Summary: A risk of occult uterine sarcoma in women is 1/770 to 1/10,000. Our goal is to minimize the risk of spillage due to morcellation and balance it with other risks due to different surgical approaches. In case of a presence of sarcoma risk factors, any form of morcellation should be contraindicated. Power morcellation should be limited to myomectomies. In peri- and postmenopausal age, an endometrial biopsy is highly recommended before surgery with expected morcellation. It is important to explain to the patient the risks of morcellation and the risks and benefits of different surgical approaches. Finally, women should be informed that the prognosis of leiomyosarcoma is poor regardless of the method of removal.
Název v anglickém jazyce
Morcellation of the Uterus: Is There Any Place?
Popis výsledku anglicky
Purpose of Review: This paper aims to review recent findings related to uterine morcellation. Recent Findings: In 2014, the US Food and Drug Administration (FDA) issued a safety communication warning against the use of laparoscopic power morcellators. Summary: A risk of occult uterine sarcoma in women is 1/770 to 1/10,000. Our goal is to minimize the risk of spillage due to morcellation and balance it with other risks due to different surgical approaches. In case of a presence of sarcoma risk factors, any form of morcellation should be contraindicated. Power morcellation should be limited to myomectomies. In peri- and postmenopausal age, an endometrial biopsy is highly recommended before surgery with expected morcellation. It is important to explain to the patient the risks of morcellation and the risks and benefits of different surgical approaches. Finally, women should be informed that the prognosis of leiomyosarcoma is poor regardless of the method of removal.
Klasifikace
Druh
J<sub>imp</sub> - Článek v periodiku v databázi Web of Science
CEP obor
—
OECD FORD obor
30214 - Obstetrics and gynaecology
Návaznosti výsledku
Projekt
—
Návaznosti
I - Institucionalni podpora na dlouhodoby koncepcni rozvoj vyzkumne organizace
Ostatní
Rok uplatnění
2020
Kód důvěrnosti údajů
S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů
Údaje specifické pro druh výsledku
Název periodika
Current Oncology Reports
ISSN
1523-3790
e-ISSN
—
Svazek periodika
22
Číslo periodika v rámci svazku
7
Stát vydavatele periodika
US - Spojené státy americké
Počet stran výsledku
6
Strana od-do
"Article 68"
Kód UT WoS článku
000540911700002
EID výsledku v databázi Scopus
2-s2.0-85086156521